Your institution may have access to this item. Find your institution then sign in to continue.
Title
New technology for ulcerative colitis launched in SA.
Abstract
The article mentions that new researches in new medical technologies has launched MMX technology to treat ulcerative colitis (UC), in South Africa. It talks about Mezavant medicine which is a complex made of Mesalamine is the main medicine of UC. The article includes the effects of this disease on stomach and why this research was important.